1. Academic Validation
  2. Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways

Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways

  • Cell. 2002 May 17;109(4):459-72. doi: 10.1016/s0092-8674(02)00747-x.
Toshiyasu Taniguchi 1 Irene Garcia-Higuera Bo Xu Paul R Andreassen Richard C Gregory Seong-Tae Kim William S Lane Michael B Kastan Alan D D'Andrea
Affiliations

Affiliation

  • 1 Department of Pediatric Oncology, Dana-Farber Cancer Institute and Department of Pediatrics, Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Abstract

Fanconi anemia (FA) and ataxia telangiectasia (AT) are clinically distinct autosomal recessive disorders characterized by spontaneous chromosome breakage and hematological cancers. FA cells are hypersensitive to mitomycin C (MMC), while AT cells are hypersensitive to ionizing radiation (IR). Here, we identify the Fanconi anemia protein, FANCD2, as a link between the FA and ATM damage response pathways. ATM phosphorylates FANCD2 on serine 222 in vitro. This site is also phosphorylated in vivo in an ATM-dependent manner following IR. Phosphorylation of FANCD2 is required for activation of an S phase checkpoint. The ATM-dependent phosphorylation of FANCD2 on S222 and the FA pathway-dependent monoubiquitination of FANCD2 on K561 are independent posttranslational modifications regulating discrete cellular signaling pathways. Biallelic disruption of FANCD2 results in both MMC and IR hypersensitivity.

Figures